How are weight loss medications, like Ozempic, reshaping obstructive sleep apnea care? In this episode of the BackTable ENT podcast, host Dr. Gopi Shah discusses emerging weight loss medications and their impact on obstructive sleep apnea (OSA) with Dr. John Carter, a neurologist and sleep specialist, and Dr. Michael Weber, an otolaryngologist.

---

SYNPOSIS

The doctors examine optimal candidates for GLP-1 medications, their side effects, and how these drugs integrate into current OSA treatment pathways. The conversation delves into patients’ experiences, new research findings, and the implications for future sleep apnea management and weight loss strategies. In sum, the episode highlights the promising role of GLP-1 medications while addressing potential challenges and unanswered questions.

---

TIMESTAMPS

00:00 - Introduction

03:06 - Understanding Weight Loss Medications

06:18 - Impact of Weight Loss on OSA

12:56 - Clinical Trials and Research

18:57 - Future of OSA Management

23:19 - Challenges and Considerations

29:27 - Pediatric Considerations

37:05 - Final Thoughts and Contact Information

---

RESOURCES

Dr. John Carter Profile

https://www.metrohealth.org/physician/john-carter-176808

Dr. Michael Weber

https://www.metrohealth.org/physician/michael-weber-174663

BackTable+ for ENT

https://plus.backtable.com/pages/ent

Check out BackTable+ for ENT, our sponsor and new e-learning platform! https://plus.backtable.com/pages/ent